using sublines of the walker 256 carcinoma , differing in the pattern of bone involvement , etidronate was found to inhibit hypercalcemia caused by systemically acting humoral factors , to inhibit bone metastasis following inoculation of tumor cells into the abdominal aorta , and to reduce the invasion of bone adjacent to tumors .
C0086268
etidronate
C0020437
hypercalcemia